Alithia Life Sciences

It certainly feels like an understatement to say that the recent development and adoption of generative artificial intelligence (or GenAI) has been exponential. In fact, a recent survey commissioned by SAS and conducted by Coleman Parkes has shown Australia is fourth in the world for its “usage and maturity” in GenAI, behind only China, the United Kingdom and the United States. It would not be unreasonable to think that we have only just scraped the surface of how this technology can be utilised in the life sciences and biotechnology sectors. We are excited by the transformative impact it could have in accelerating new health and medical research discoveries. If your business is already leveraging GenAI in this way, we would love for you to share your insights in the comments below. #artificialintelligence #generativeai #GenAI

The Alithia Life Sciences and PureCDM teams congratulate 360biolabs, a BioAgilytix company on the opening of their new cutting-edge facility in Melbourne.  Our Founder and Director, A/Prof Tina Soulis, along with Majella Hamilton and Helen P., were lucky enough to attend yesterday’s ribbon-cutting ceremony, and were wowed by the purpose-built, state of-the-art laboratories on display.  Having worked collaboratively and travelled with the 360biolabs team (especially Sharon S.) for many years, we know that this milestone marks an exciting new chapter in their company’s history, and we look forward to following the medical research breakthroughs this new facility will help make possible. Well done to everyone involved in the project. #360biolabs #biotech #biotechnologyindustry #medicalresearch #laboratories #cuttingedge #stateoftheart #innovation #melbourne #australia

Yesterday, Alithia Life Sciences and PureCDM, represented by Majella Hamilton and Helen P., had the pleasure of attending a Biotech Showcase hosted by PEAK Asset Management, FB Rice and Monsoon Communications.  The event featured interesting presentations from eight prominent biotech companies - Neuren Pharmaceuticals Limited, Mesoblast Limited, Dimerix Limited, CLINUVEL PHARMACEUTICALS LTD, AdAlta Ltd, Syntara, Opthea and Biotron Ltd.  They were complemented by an insightful and informative panel discussion on biotech sector investment strategies, involving Deborah Rathjen (Carina Biotech), Mara Macdonald (Brandon Capital), Mark Pachacz (Bioshares), Matt McNamara (Horizon 3 Healthcare), Rhenu Bhuller (AusBiotech) and Anton Whitehead (Ex-Bell Potter).  Our thanks to the organisers, as well as to all of the participants that gave their time to make it such a value-adding afternoon for everyone in attendance. While we couldn’t talk to everyone in the room, rest assured, we remain ready and eager to support any companies progressing projects in this space. #biotech #biotechnologyindustry #biotechshowcase #healthcare #innovation #investment

Did you know that 1 in 45 Australians live with a brain injury? This week is Brain Injury Awareness Week in Australia, an annual campaign by Synapse - Australia's Brain Injury Organisation. The focus of this year’s campaign is “What’s your connection”, drawing attention to the fact that people are connected by brain injury, even if no two brain injuries are the same. As a business that helps to progress novel solutions to difficult brain conditions, we are passionate about supporting this cause.  If you can relate to this theme, and feel comfortable doing so, please share your connection to brain injury in the comments below. Event website: https://lnkd.in/gHTw_-aK #BIAW24 #WhatsYourConnection #braininjury 

Last Thursday evening, our Director of Clinical Operations, Samantha George, attended an MTPConnect Adelaide Intermediary Program event on the topic of Disruptive Femtech Innovations. The event was truly inspiring but also highlighted a critical issue: funding bodies are not actively investing in women's health innovations. Key topics included endometriosis, neuroimmune pain in women, and AI for embryo viability — just a few examples of pressing issues in women’s health. It's concerning that these important areas are often overlooked in terms of investment and discussion. We need to address this generational gender bias and push for more support and innovation in women's health. #womenshealth #femtech #innovation

Agitation and aggression are common symptoms in dementia, affecting the quality of life of both patients and their caregivers. For that reason, it is exciting to hear this week that Kinoxis Therapeutics Pty Ltd will be able to progress a Phase II clinical trial testing the safety and efficacy of its novel drug, KNX100, as a treatment for such symptoms. We send our congratulations to all involved in raising this new funding and look forward to supporting this important research. #dementia #agitation #medicalresearch #fundingannouncement

We attended a fantastic BioMelbourne Network symposium on radiopharmaceuticals today, highlighting Victoria's and Australia's leadership in the field with insights from Telix Pharmaceuticals Limited, Peter MacCallum Cancer Centre and Cyclotek Pty Ltd. We are incredibly proud that Alithia Life Sciences has contributed to numerous clinical studies involving radioligands and radiopharmaceuticals, furthering innovation in this crucial area. #radiopharmaceuticals #radioligands #innovation #victoria #australia

National Science Week is currently underway in Australia. An annual Australian Government initiative, it seeks to celebrate science and technology in our nation by both recognising the past achievements of Australian scientists and fostering a passion that will inspire the next generation of Australian innovators. With more than 1000 events taking place across the country, visit the event website to find out what is happening near you. Event website: https://lnkd.in/gwDVU2q #nationalscienceweek #scienceandtechnology #innovation #australia

Are you a researcher or inventor that is in need of support to progress an innovative solution to an identified need?  If you are, then why not apply to pitch your project at AusBiotech’s Early Stage Innovation Forum, part of their upcoming national conference in Melbourne on October 30 and November 1, 2024.  Visit the below link to learn more about this opportunity and to register your interest to present before September 1. The Alithia Life Sciences team will be in attendance and looks forward to hearing the vast array of novel ideas. #biotech #biotechnologyindustry #innovation #australia

This week, the Alithia Life Sciences team has travelled from around Australia to congregate in Melbourne for a two day strategy meeting. In addition to reviewing the objectives and needs of both current and future projects, this event has provided a great opportunity for self-reflection, focussing on how we can maximise the strengths of every team member to benefit both the business and our valued clients. Workshop activities on work styles and personalities have proved incredibly useful in this regard, and have been complemented by training sessions led by guest speakers from Cerulea Clinical Trials and our strategic partner PureCDM. We thank both of those organisations for their participation and insights, and extend our gratitude to Prime Financial Group and The Save Group for helping make the meeting possible. Now, it is back to work! #strategy #teambuilding #contractresearchorganisation #lifesciences #biotechnology